Amphenol: Strong Growth In IT Datacom Market
Summary
- I reiterate a Buy rating on Amphenol Corporation stock with a one-year target price of $87 per APH share, driven by strong product demands and robust financial performance.
- Amphenol posted 33% organic revenue growth and 57.5% adjusted EPS growth, driven by strong market demands in the IT datacom market.
- The acquisition of LifeSync aligns with Amphenol’s M&A strategy, potentially adding $100 million in revenue from the medical device market.
- With a robust balance sheet and strong market demands, Amphenol is well-positioned for continued growth, especially in AI applications and IT datacom.
Analyst’s Disclosure: I/we have a beneficial long position in the shares of APH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.